As per the Delveinsight, the market size of Aneurysmal Subarachnoid Hemorrhage (aSAH) in 7MM was USD 155.47 Million in 2017.
The total incident cases of Aneurysmal Subarachnoid Hemorrhage (aSAH) in 7MM was 53,611 in 2017. It is observed that the incident population share of aSAH in the United States was 24.5% of the total 7MM share.
New potential targets for therapeutics development and strengthening of the molecular basis of SAH are the key drivers for Aneurysmal Subarachnoid Hemorrhage (aSAH) Market.
Some of the key companies in the Aneurysmal Subarachnoid Hemorrhage (aSAH) Market include Evgen Pharma, Idorsia Pharmaceuticals, Grace Therapeutics, Edge Therapeutics, PDS Biotechnology Corporation, BIT Pharma and many others.
Source: Aneurysmal Subarachnoid Hemorrhage (aSAH) Market Growth Analysis